Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

Data from Northumberland County Council shows that just a third of adults in the county are at a healthy weight.

People living in rural areas are at greater risk for obesity than the general population, and they often have limited access ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

A doctor warned of re-emerging cases of scurvy, a disease caused by vitamin C deficiency, among children and young people in ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

A doctor has said the disease 'is something out of books from pirate stories' and its reoccurrence is 'tragic' ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

A team of researchers from UNIGE and HUG reveals that the majority of tweets published about obesity between 2019 and 2022 ...